Results 31 to 40 of about 87,204 (257)
Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro. [PDF]
The success of Imatinib (IM) therapy in chronic myeloid leukemia (CML) is compromised by the development of IM resistance and by a limited IM effect on hematopoietic stem cells.
Carsten Bokemeyer +40 more
core +2 more sources
Physapruin A (PHA), a Physalis peruviana-derived withanolide, exhibits antiproliferation activity against oral and breast cancer cells. However, its potential antitumor effects in combined treatments remain unclear.
Sheng-Yao Peng +5 more
doaj +1 more source
Processing and Thermomechanical Properties of PHA
The biodegradability and biocompatibility of PHAs make them a class of materials with wide range of applications, raising interest of scientist and industries.
Vito Gigante +5 more
core +1 more source
In this work, the polydopamine (PDA) coating layer was first applied to modify hydroxyapatite (HA) nanoparticles and then the functional PDA/HA (pHA) composite nanoparticles were obtained.
Z. X. Cui +6 more
doaj +1 more source
Background Leukocyte phytohemagglutinin (PHA-L), derived from the L4 tetramer of PHA, has been frequently employed as a mitogen to induce T lymphocyte proliferation in vitro.
Peipei Wang +9 more
doaj +1 more source
The composition of polyhydroxyalkanoate (PHA) monomers affects the properties and final applications of PHA polymers. This study focused on the feasibility of producing tailored PHA differing in hydroxyvalerate (HV) content, through manipulation of the ...
Mónica Carvalheira +4 more
doaj +1 more source
PHA production characteristics.
High-throughput screening (HTS) methods for characterization of microbial production of polyhydroxyalkanoates (PHA) are currently under investigated, despite the advent of such systems in related fields. In this study, phenotypic microarray by Biolog PM1
Piotr Jablonski (3133044) +5 more
core +1 more source
MRI Detection and Therapeutic Enhancement of Ferumoxytol Internalization in Glioblastoma Cells
Recently, the FDA-approved iron oxide nanoparticle, ferumoxytol, has been found to enhance the efficacy of pharmacological ascorbate (AscH−) in treating glioblastoma, as AscH− reduces the Fe3+ sites in the nanoparticle core.
Michael S. Petronek +4 more
doaj +1 more source

